Back

AI-Driven Plasma Denaturation Profiling for Multi-Cancer Detection

Tsvetkov, P. O.; Eyraud, R.; Ayache, S.; Baksheeva, V.; Bertucci, A.; Mogenet, A.; Tomasini, P.; de Rauglaudre, B.; Dahan, L.; Gaudy-Marquestre, C.; Kalidindi, S. S. S.; Buffat, C.; Dehais, C.; Astier, A.; Ouafik, L.; Gorokhova, S.; Tabouret, E.; Devred, F.

2025-03-27 oncology
10.1101/2025.03.26.25324680 medRxiv
Show abstract

Many cancers cannot be detected early due to lack of effective disease biomarkers, leading to poor prognosis. We applied an existing biophysical technology nanoDSF in a novel way to answer this unmet biomedical need. We developed a breakthrough digital biomarker method for cancer detection based on AI-classification of plasma denaturation profiles (PDPs) obtained by nanoDSF technology. PDPs from 300 plasma samples from patients with melanoma, brain, digestive or lung cancers were automatically distinguished from healthy profiles with an accuracy of 94%. Moreover, our method was able to distinguish different types of cancers from each other with an accuracy of 80%, making it an effective way to help cancer diagnosis and monitoring. Our technology thus paves the way for a long-sought multi-cancer early detection (MCED) test that is blood-based, cost-effective and easy-to-implement in any clinical setting.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.